MedPath

MODERIBA

MODERIBA

Discontinued
DIN Number

02436396

Drug Class

Human

Market Date

Feb 17, 2015

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02436396
AIG Number0111643004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AP01 RIBAVIRIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.32
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIBAVIRINActive
Strength: 200 MG
Monograph: RIBAVIRIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.